NovoCure (NVCR) Other Non-Current Assets (2014 - 2026)

NovoCure (NVCR) has reported Other Non-Current Assets for 13 consecutive years, with $10.9 million the latest figure, recorded in Q2 2026.

• Quarterly Other Non-Current Assets fell 29.77% year-over-year to $10.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $10.9 million (down 29.77% YoY) and the FY2025 annual result came in at $10.6 million, down 27.51% from the prior year.
• Other Non-Current Assets slipped to $10.9 million in Q2 2026 per NVCR's latest filing, from $11.2 million in the prior quarter.
• Over the last five years, Other Non-Current Assets for NVCR reached as high as $15.6 million in Q2 2025 and fell as low as $10.6 million in Q4 2025.
• A 5-year average of $12.5 million and a median of $12.1 million in 2024 frame the typical range for Other Non-Current Assets.
• Annual changes were most pronounced in 2023 — Other Non-Current Assets jumped 33.71% — and 2026, when it retreated 29.77%.
• Year by year, Other Non-Current Assets stood at $11.2 million in 2022, then advanced by 25.63% to $14.0 million in 2023, then rose by 4.25% to $14.6 million in 2024, then decreased by 27.51% to $10.6 million in 2025, then increased by 3.15% to $10.9 million in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $10.9 million, $11.2 million, and $10.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.